Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome
Many patients with irritable bowel syndrome (IBS) are disillusioned by the lack of efficacy of treatments and suffer from numerous symptoms not covered by the Rome criteria for IBS, as the current empirical treatment regimens fail to address these persistent debilitating ‘IBS associated symptoms’. T...
Gespeichert in:
Veröffentlicht in: | European journal of gastroenterology & hepatology 2005-01, Vol.17 (1), p.21-26 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!